NutraPectin utilizes green extraction technology to convert citrus peel waste into a high-purity, pectin-rich nutraceutical. This supplement helps manage metabolic health by slowing sugar and lipid absorption, offering a sustainable, affordable solution for preventing lifestyle diseases like diabetes and obesity. Currently in the early commercialization phase, the project is seeking corporate partnerships and funding to scale from lab prototype to industrial pilot production.
NutraPectin is a biotechnology research project focused on the production of a high-purity, pectin-rich nutraceutical supplement derived from discarded citrus peel waste. By utilizing a sustainable green extraction process, this technology addresses two critical issues simultaneously: the reduction of agricultural and food-processing waste and the creation of an affordable, locally produced solution for managing lifestyle diseases. This supplement is designed to support metabolic health by slowing sugar and lipid absorption, providing a preventative tool against diabetes, obesity, and high cholesterol. The project aims to improve the accessibility of healthcare products in low-income communities while promoting circular economy practices within the citrus industry.
The project is currently at TRL 4, as it has moved beyond basic conceptual research and is undergoing laboratory-level validation and production pathway optimization. It has been awarded a Technology Innovation Agency (TIA) Seed Grant and received industry recognition via the 2024 Catalyst biotech competition, which provides ongoing support for technical refinement and business development. The team is currently seeking partnerships and funding to facilitate pilot-scale production and regulatory...
UP is a comprehensive, multi‑campus public research university in Pretoria with a broad disciplinary base and significant postgraduate activity. Industry engages through co‑located, large‑scale labs at the Engineering 4.0 campus—home to national reference and training facilities developed with SANRAL and partners—and through clinical pathways via Steve Biko Academic Hospital. For streamlined collaboration, Enterprises University of Pretoria serves as a single contracting gateway for contract research and consulting, while a dedicated Technology Transfer Office manages IP and licensing. Research is supported by South Africa’s National Research Foundation and the South African Medical Research Council, alongside international sponsors. Startup creation is enabled by the on‑campus TuksNovation incubator.